A Preliminary Study of the Complement Component 1q Levels in Predicting the Efficacy of Combined Immunotherapy in Patients with Lung Cancer

A Preliminary Study of the Complement Component 1q Levels in Predicting the Efficacy of Combined Immunotherapy in Patients with Lung Cancer

Daoming Zhang,1 Yuan Li,1 Haoyue Li,2 Tian Tang,1 Yongfa Zheng,1 Xufeng Guo,1 Ximing Xu1 1Cancer Center, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China; 2Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of ChinaCorrespondence: Ximing XuC...

Full description

Bibliographic Details
Main Authors: Zhang D, Li Y, Li H, Tang T, Zheng Y, Guo X, Xu X
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Cancer Management and Research
Subjects:
immunotherapy
efficacy prediction
complement component 1q
Online Access:https://www.dovepress.com/a-preliminary-study-of-the-complement-component-1q-levels-in-predictin-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/a-preliminary-study-of-the-complement-component-1q-levels-in-predictin-peer-reviewed-fulltext-article-CMAR

Similar Items